Changes to Grant Support Enters Transition Phase
The first phase of transformation has been implemented. Position
descriptions have been changed in the Office of Sponsored
Research and in each of the three divisions, both at the
Department/Program level and at the Program Support Level.
This change means an investigator who is going to apply
for funding now has a team of 3 to assist them.
| • |
Grant Administrators (GA) who in most cases are
already providing some type of support as Research or
Administrative or Program Associates, will assist in
preparing the proposal, performing such tasks as
creating/obtaining biosketches, creating/updating other
support information, routing completed Internal Forms,
and anything else the Principal Investigator might
request.
|
| • |
Research Financial Analysts (RFA) (formerly Grant &
Contract Specialists) will develop a budget and budget
narrative with the PI and Grant Administrator.
|
| • |
Sponsored Research Administrators (SRA) in the
Office of Sponsored Research will accept completed
applications with a minimum of 48 hours (2 days)
provided to review the proposal in its entirety before
submission. Applications with errors or omissions will
be returned for correction/s. During this period of
transition, OSR staff will provide training and
assistance to the GAs and RFAs, and faculty can always
call their Sponsored Research Administrator with
questions about submissions. |
If you have any questions about these transformations, please
contact your Division Administrator (Kara O'Neil
Mercedes Robaina or
Wanda Williamson) and for
the Office of Sponsored Research, please contact
Jane O'Connor.
|
|
NIH Announces Changes to Submission Policy for Some Awards
The NIH has announced that, effective immediately, it will accept a new
(A0) application following an unsuccessful resubmission (A1)
application. The subsequent new application need not
demonstrate substantial changes in scientific direction compared
to previously reviewed submissions, and must not contain an
introduction to respond to the critiques from the previous
review.
This alters a policy in effect since 2009 that
permitted only one "resubmission" after an application was
rejected and "stipulated that any subsequent submission for that
project must demonstrate significant changes in scientific
direction compared to the previous submissions."
The new policy, which applies to certain funding from NIH and
the Agency for Healthcare Research and Quality, is described as
a change to the resubmission policy below, but it actually
addresses what may be considered a new submission. Resubmissions
are still limited to one.
NIH Policy Notice |
NIH Blog Describing Change
|
|
NCI Standard Funding Announcements
|
|
NEW |
| May 2 |
Physician Scientist |
Non-Federal |
Drug Discovery |
Harrington Discovery Institute-University Hospitals-Case Medical Center -
Harrington Scholar-Innovator Grant
Recognizes physician-scientists whose research has potential to
change standard of care. Award provides research and drug
development funding as well as non-financial support to selected
investigators and their institutions to help bridge the gap
between basic discovery and clinical introduction.
| Due Date |
May 2 (LOI)
July 30 (Invited App to OSR)
August 1 (Sponsor) |
| Amount & Project Period: |
$100,000 total over 2 years |
| Eligibility: |
All Physician Scientist with MD or MD/PhD |
| Contact: |
Linda
Nolan x6701 |
| RFA Link: |
Harrington Scholar Innovator Grant |
|
NEW |
| May 6 (LOI) |
Postdocs |
Non-Federal |
Ovarian Cancer |
Ovarian Cancer Research Fund - 2015 Anne Schreiber Mentored Investigator Award
For post-doctoral trainees working under the supervision of an experienced mentor in ovarian cancer or relevant area.
| Due Date |
May 6 (LOI)
July 30 (Completed Invited applications to OSR)
August 1 (Sponsor) |
| Amount & Project Period: |
$75,000 - 2 years
|
| Eligibility: |
Postdoctoral Trainees with 90% overall research effort required.
|
| Contact: |
Linda
Nolan x6701
|
| RFA Link: |
Anne Schreiber Mentored Investigator Award
|
|
|
NEW |
| May 6 (LOI) |
All Faculty |
Non-Federal |
Ovarian Cancer |
Ovarian Cancer Research Fund - 2015 Program Project Development Grants
Research projects that may involve several investigators within
one institution or collaborations among groups in multiple
institutions seeking to develop program project grants for
subsequent applications to NIH.
| Due Date |
May 6 (LOI)
July 30 Invited Applications (OSR)
August 1 (Sponsor)
|
| Amount & Project Period: |
$900,000 - 3 years (1 competitive renewal
allowed)
|
| Eligibility: |
All Faculty
|
| Contact: |
Linda
Nolan x6701
|
| RFA Link: |
2015
Program Project Development Grant
|
|
|
NEW |
| May 6 (LOI) |
Jr. Faculty |
Non-Federal |
Ovarian Cancer |
Ovarian Cancer Research Fund - 2015 Liz Tilberis Early Career Award
For junior faculty with a strong commitment to an investigative
career in the field of ovarian cancer research The intent of
these awards is to support a substantial time commitment to
research and academic endeavors in ovarian cancer.
| Due Date |
May 6 (LOI)
Invited applications:
July 30 (OSR)
August 1 (Sponsor) |
| Amount & Project Period: |
$450,000 - 3 years
|
| Eligibility: |
Assistant Professor within first 5 years of
first appointment,
Certify at least 75% time dedicated to ovarian cancer research.
|
| Contact: |
Linda
Nolan, x6071
|
| RFA Link: |
2015 Liz Tilberis Early Career Award
|
|
NEW |
May 7 (LOI)
July 30 (OSR)
August 1 (Sponsor) |
Postdocs/Jr. Faculty |
Non-Federal |
Hematology |
American Society of Hematology (ASH) - Fellow and Jr.
Faculty Scholar Awards
Proposals accepted in Basic/Translational research and Clinical Research to include
patient-oriented and outcomes-based research that include significant interaction with patients.
| Due Date |
May 7 (LOI)
Completed Applications Due:
July 30 (OSR)
August 1 (Sponsor)
|
| Amount & Project Period: |
$100,000 - 3 years (Fellow Scholars)
$150,000 - 3 years (Jr. Faculty Scholars)
|
| Eligibility: |
ASH Membership required at time of LOI
Submission
|
| Contact: |
Linda Nolan x6701
|
| RFA Link: |
ASH Scholar Awards
|
|
NEW
|
May 9 (LOI)
June 6 (OSR)
June 9 (Sponsor) |
All Faculty |
Federal |
Physical Sciences/Oncology |
Physical Sciences-Oncology Network (PS-ON): Physical
Sciences-Oncology Centers (PS-OC) (U54)
The PS-OCs will support transdisciplinary research that: (1)
Establishes a physical sciences perspective w/in the cancer
research community; (2) Facilitates team science & field
convergence at intersection of physical sciences and cancer
research; and (3) Collectively tests physical sciences-based
experimental & theoretical concepts of cancer and promotes
innovative solutions addressing outstanding questions in cancer
research.
| Due Date |
May 9 (LOI)
Completed Applications:
June 6 (OSR)
June 9 (Sponsor) |
| Amount & Project Period: |
$1.5 million/yr (Direct Costs) - 5 years
|
| Eligibility: |
Use of the multi-PD/PI mechanism encouraged.
PD/PI (contact PD/PI for applications with multiple PDs/PIs) must be
a scientist with formal training and expertise in the physical sciences
and/or engineering. Must also include an additional PD/PI or other
senior/key person with primary expertise in cancer research and/or
oncology.
|
| Contact: |
Linda Nolan x6701
|
| RFA Link: |
PAR-14-169
|
|
NEW |
| May 13 (Pre-application) |
Established Faculty |
Federal |
Bone Marrow Failure |
Bone Marrow Failure Research Program (BMFRP) Idea
Development Award
Proposed projects should include a well-formulated, testable
hypothesis based on strong scientific rationale and a developed
and well-articulated research approach. Personnel on the
proposed team should have a strong background in BMF research.
| Due Date |
May 13 (Pre-Applications)
Completed Application Due:
August 26 (OSR)
August 28 (Sponsor) |
| Amount & Project Period: |
$400,000 Direct Costs - 3 years |
| Eligibility: |
At or above Assistant Professor established in
the field.
|
| Contact: |
Linda Nolan x6701
|
| RFA Link: |
W81XWH-14-BMFRP-IDA
|
|
|
NEW |
| May 14 (Pre-app) |
Established Faculty |
Federal |
Breast Cancer |
Breast Cancer Research Program (BCRP) Innovator Award
To support the most novel, visionary, high-risk ideas from
innovative investigators who are recognized by this award.
New Submission System: Electronic Biomedical
Research Application Portal (eBRAP).
Principal Investigators must register in eBRAP to submit
pre-application
| Due Date |
May 14 (Pre-applications)
Invited Applications Due:
August 13 (OSR)
August 15 (Sponsor) |
| Amount & Project Period: |
$5,000,000 (Direct Costs) - 5 years |
| Eligibility: |
Faculty above Associate Professor
established in his/her field. |
| Contact: |
Linda Nolan x6701 |
| RFA Link: |
W81XWH-14-BCRP-INNOV
|
|
|
NEW |
| May 14 (Pre-app) |
Postdoc Fellows/
All Faculty |
Federal |
Breast Cancer |
Breast Cancer Research Program (BCRP) Breakthrough Award
Levels 1 and 2
Research w/potential to lead to or make breakthroughs in breast
cancer. Critical components include potential for major impact &
acceleration of progress on ending breast cancer; and research
scope of small to large-scale projects at different stages of
idea and research development.
Funding Level 1 is for projects in the earliest
stages of idea development with potential for new avenues of
investigation. No preliminary data required.
Funding Level 2 is for projects supported by
preliminary data with potential for significant advancements
toward clinical translation.
New Submission System: Electronic
Biomedical Research Application Portal (eBRAP).
Principal Investigators must register in eBRAP to submit
pre-application
To promote research on quantitative imaging of tumor response to cancer
therapies in clinical trial settings, with the overall goal of
facilitating clinical decision making.
Due Date
|
May 14 (Pre-applications)
Completed applications:
May 23 (OSR)
May 28 (Sponsor) |
| Amount & Project Period: |
Funding Level I - $350,000 (Direct Costs) - 3 years
Funding Level 2 - $700,000 (Direct Costs) - 3 years |
| Eligibility: |
Postdoctoral Fellows are eligible and
encouraged to apply.
Investigators at all academic levels are also eligible. |
| Contact: |
Linda Nolan x6701 |
| RFA Link: |
W81XWH-14-BCRP-BREAKTHROUGH12 |
|
|
NEW |
May 14 (Pre-app)
|
Established Faculty |
Federal |
Breast Cancer |
Breast Cancer Research Program (BCRP) Breakthrough Award
Levels 3 and 4
Research w/potential to lead to or make breakthroughs in breast
cancer. Critical components include potential for major impact &
acceleration of progress on ending breast cancer; and research
scope of small to large-scale projects at different stages of
idea and research development.
| Due Date |
May 14 (Pre-applications)
Completed applications due:
August 13 (OSR)
August 15 (Sponsor)
|
| Amount & Project Period: |
Funding Level 3 - $2.5 Million (Direct Costs) - 5 years
Funding Level 4 - $10 Million (Direct Costs) - 5 years
|
| Eligibility: |
Established Ranks
|
| Contact: |
Linda Nolan x6701
|
| RFA Link: |
W81XWH-14-BCRP-BREAKTHROUGH34
|
|
 |
May 14 (OSR)
May 16 (Sponsor) |
Predocs/Postdocs/
Jr. Faculty |
Non-federal |
Quantifying Benefits in Cancer Tx |
Assessing the Benefits of Treating Cancer
Supports research aimed at quantifying the benefits accrued from
innovations in cancer treatment; focuses on developing a novel
way of quantifying or describing the social, patient-centered,
and economic benefits of innovation in cancer treatment. Not
intended for clinical or bench research. Offered are a
pre-doctoral fellowship, post-doctoral fellowship and research
starter grant for junior faculty.
|
NEW
|
| May 15 (LOI) |
Research/
Clinical Postdocs |
Non-federal |
HIV/AIDS |
Mathilde Krim Fellowships in Basic Biomedical Research
Encourages postdocs w/limited experience and demonstrated
interest in HIV/AIDS to redirect or to embark on a career in
biomedical HIV/AIDS research mentored by an experienced
investigator (from same institution) qualified to oversee the
proposed research.
| Due Date |
May 15 (Letter of Intent)
Invited Submission:
July 8 (OSR)
July 10* (Sponsor)
*Sponsor due date is tentative at time of publication.
|
| Amount & Project Period: |
$150,000 (total costs) - 2 years
|
| Eligibility: |
Applicants must 1) hold a research or clinical
doctorate completed between 3 and 6 years; 2) be
positioned to secure an independent research position by March 2017; 3)
be the main author on significant publications and 4) have made oral and
poster presentations at major scientific meetings and conferences. |
| Contact: |
Linda Nolan x6701
|
| RFA Link: |
Mathilde Krim Fellowships in Basic Biomedical
Research
|
|
|
NEW
|
May 16 (OSR)
May 20 (Sponsor |
Faculty & Postdocs |
Federal |
Molecular Analysis |
Early-Stage Innovative Molecular Analysis Technology
Development for Cancer Research
Exploratory research focused on the inception and development of early
stage, highly innovative, technologies or emerging technologies
with significant transformative potential that has not yet been
explored in a cancer-relevant use.
| Due Date |
May 16 (OSR)
May 20 (Sponsor) |
| Amount & Project Period: |
$500,000 total direct costs over 3 years
|
| Eligibility: |
All Faculty
|
| Contact: |
Linda Nolan x6701
|
| RFA Link: |
RFA-CA-14-003
|
|
|
NEW
|
May 16 (OSR)
May 20 (Sponsor) |
Postdocs
& Faculty |
Federal |
Biospecimen Science |
Early-Stage Development of Innovative Technologies for
Biospecimen Science
Technically innovative feasibility studies focused on early-stage
development of technologies that address issues related to
pre-analytical variations in the collection, processing,
handling, and storage of cancer-relevant biospecimens or their
derivatives.
| Due Date |
May 16 (OSR)
May 20 (Sponsor) |
| Amount & Project Period: |
$500,000 total direct costs over 3 years
|
| Eligibility: |
All Faculty
|
| Contact: |
Linda Nolan x6701
|
| RFA Link: |
RFA-CA-14-005
|
|
NEW |
May 16 (OSR)
May 20 (Sponsor) |
Postdocs & Faculty |
Federal |
Biospecimen Science |
Validation and Advanced Development of Emerging Technologies
for Biospecimen Science
Will support the development of tools, devices, instrumentation, and
associated methods to assess sample quality, preserve sample
integrity, and establish verification criteria for quality
assessment/quality control and handling.
| Due Date |
May 16 (OSR)
May 20 (Sponsor)
|
| Amount & Project Period: |
$300,000/year Direct Costs for 3 years
|
| Eligibility: |
Postdocs and Faculty |
| Contact: |
Linda Nolan x6701 |
| RFA Link: |
RFA-CA-14-006
|
|
NEW
|
May 16 (OSR)
May 20 (Sponsor) |
All Faculty |
Federal |
Bioengineering |
Bioengineering Research Partnerships (BRP)
Awards will focus on supporting multidisciplinary teams that apply an
integrative, quantitative bioengineering approach to developing
these technologies and engage biomedical researchers or
clinicians throughout the project. The goal of the program is to
support projects that can realize meaningful solutions within
5-10 years.
| Due Date |
May 16 (OSR)
May 20 (Sponsor) |
| Amount & Project Period: |
Budget not limited - 5 years |
| Eligibility: |
All Faculty |
| Contact: |
Linda Nolan x6701 |
| RFA Link: |
PAR-14-092
|
|
NEW
|
May 19 (LOI)
June 17 (OSR)
June 19 (Sponsor) |
All Faculty |
Federal |
Big Data |
Development of Software and Analysis Methods for Biomedical
Big Data in Targeted Areas of High Need
Development of innovative analytical methods and software tools with the
objective of addressing current & emerging needs for using,
managing, and analyzing the larger and more complex data sets
inherent to biomedical Big Data. FOA has 4 focus areas: Data
Compression/Reduction, Data Visualization, Data Provenance &
Data Wrangling.
| Due Date |
May 19 (LOI)
June 17 (OSR)
June 19 (Sponsor) |
| Amount & Project Period: |
$300,000/year (Direct Costs) - 3 years
|
| Eligibility: |
All Faculty
|
| Contact: |
Linda Nolan, x6071
|
| RFA Link: |
RFA-HG-14-020
|
|
|
|
May 20 (LOI)
June 18 (OSR)
June 20 (Sponsor) |
All Faculty |
Federal |
Provocative Cancer
Questions |
Research Answers to NCI's Provocative Questions
Innovative research projects designed to solve specific problems and
paradoxes in cancer research. This is the final submission date
for these RFAs.
| Due Date |
May 20 (LOI)
June 18 (OSR)
June 20 (Sponsor) |
| Amount & Project Period: |
R01 - Unlimited funding - 4 years
R21 - $275,000 (Direct Costs) - 2 years |
| Eligibility: |
All Faculty |
| Contact: |
Linda Nolan, x6071 |
| RFA Links and related
topics for all groups: |
Group A - relates
to investigation of changes in behavior & exposure risks, mechanistic
links between cancer risk factors and biological events associated with
cancer development.
RFA-CA-13-016 (R01) |
RFA-CA-13-017 (R21)
Group B - Relates to mechanisms of tumor development or
recurrence.
RFA-CA-13-018 (R01) |
RFA-CA-13-019 (R21)
Group C - Relates to cancer detection, diagnosis, and
prognosis.
RFA-CA-13-020 (R01) |
RFA-CA-13-021 (R21)
Group D - Relates to cancer therapy.
RFA-CA-13-022 (R01) |
RFA-CA-13-023 (R21)
Group E - Relates to clinical effectiveness.
RFA-CA-024 (R01) |
RFA-CA-13-025 (R21)
|
|
NEW |
| May 22 (Pre-app) |
All Faculty |
Federal |
Ovarian Cancer |
Ovarian cancer research Program (OCRP) Pilot Award
Conceptually innovative, high-risk/high-reward research
potentially leading to critical discoveries/major advancements
to drive ovarian cancer research forward Preliminary data are
not required, but are allowed. Strength of application s/be
based on sound scientific rationale and logical reasoning.
Clinical trials will not be supported by this award mechanism.
(Optional Nested Teal Postdoctoral Scholar).
| Due Date |
May 22 (Pre-applications)
Invited Applications:
August 18 (OSR)
August 20 (Sponsor) |
| Amount & Project Period: |
$225,000 (Direct costs) - 2 years
Additional $75,000 if Teal Postdoctoral Scholar included. |
| Eligibility: |
Postdoctoral level and above.
(Nested Teal Postdoctoral Scholar is a postdoc with less than 3 years
total in postdoctoral positions at time of submission). |
| Contact: |
Linda Nolan, x6071
|
| RFA Link: |
Ovarian
Cancer Pilot Award
|
|
 |
May 21 (OSR)
May 23 (Sponsor) |
Jr. Faculty |
Non-federal |
Pediatric Cancers |
Alex's Lemonade Stand Foundation "A" Award
For the early career scientist with an original project not
currently being funded.
| Due Date |
May 21 (OSR)
May 23 (Sponsor)
|
| Amount & Project Period: |
$150,000/year - 3 years
|
| Eligibility: |
May not be ranked higher that Assistant
Professor
MD, MD/PhD applicants must be less than 6 years after finishing
3-year fellowship at time of award.
|
| Contact: |
Linda
Nolan, x6071
|
| RFA Link: |
"A"
Awards |
Alex's Lemonade
Stand Foundation Guidelines
|
|
NEW |
May 29 (OSR)
May 31 (Sponsor) |
Jr. Faculty |
Non-federal |
Cancer Management |
The Doctors Cancer Foundation
Interested in promoting the best of the young scientists,
currently under the radar screen; NOT looking at studies that
show that drug A is 3% better than drug B. The project should
be innovative, sound and be able to lead to clinical trials.
|
NEW |
May 29 (OSR)
June 1 (Sponsor) |
Jr. Faculty |
Non-federal |
Brain Tumors |
B*Cured Clinical Research Investigator Award
Supports research dedicated to a cure for malignant brain tumors.
| Due Date |
May 29 (OSR)
June 01 (Sponsor) |
| Amount & Project Period: |
$500,000 - 2 years
|
| Eligibility: |
Jr. Faculty intending to apply for NIH R01
funding or equivalent within 5 years and do not have independent funding
for proposed research.
|
| Contact: |
Linda Nolan, x6071
|
| RFA Link: |
B*Cured
Clinical Research Investigator Award
|
|
NEW |
| June 3 (Pre-app) |
Jr. Faculty |
Non-federal |
Brain Tumors |
Lung Cancer Research Program (LCRP) - Career Development Award
Supports early-career, independent
investigators to conduct impactful research under the mentorship
of an experienced lung cancer researcher, and is intended to
support impactful research projects with emphasis on discovery.
| Due Date |
June 3 - Pre-application
Invited Applications Due:
September 15 (OSR)
September 17 (Sponsor) |
| Amount & Project Period: |
$240,000 (Direct Costs) - 2 years
|
| Eligibility: |
Applicants must be an Assistant Professor or Instructor within 5 years of
first faculty appointment and 40% protected time for the proposed project.
Mentor must be Associate Professor or higher and have a proven publication record in lung cancer research. |
| Contact: |
Linda
Nolan, x6071
|
| RFA Link: |
W81XWH-14-LCRP-CDA
|
|
|
NEW |
| June 3 (Pre-app) |
All Faculty |
Federal |
Lung Cancer |
Clinical Exploration Award (W81XWH-14-LCRP-CEA)
Early-phase, proof-of-principle clinical trials and correlative studies to
investigate hypothesis-based, innovative interventions that have
the potential to resolve current clinical barriers and result in
a profound impact on the clinical management of lung cancer.
| Due Date |
June 3 (Pre-applications)
Invited Applications:
September 15 (OSR)
September 17 (Sponsor) |
| Amount & Project Period: |
$450,000 direct costs - 3 years (Clinical
Trials)
$250,000 direct costs - 2 years (Correlative Studies) |
| Eligibility: |
Independent investigator at or above Assistant
Professor
|
| Contact: |
Linda
Nolan, x6071
|
| RFA Link: |
W81XWH-14-LCRP-CEA
|
|
|
NEW |
| June 3 (LOI) |
All Faculty |
Federal |
Lung Cancer |
Idea Development (W81XWH-14-LCRP-IDA)
Promotes new ideas in early stages of development and having potential to
yield impactful data and new avenues of investigation.
Preliminary data supporting feasibility of research hypotheses
and approaches are required; however, data does not necessarily
need to be in lung cancer. Applications encouraged from new
investigators
| Due Date |
June 3 - Pre-applications
Invited applications:
September 15 (OSR) |
September 17 (Sponsor) |
| Amount & Project Period: |
$350,000 - 2 years
|
| Eligibility: |
New and established faculty investigators.
|
| Contact: |
Linda
Nolan, x6071
|
| RFA Link: |
Lung Cancer Research
Program (LCRP)
|
|
NEW |
| June 3 (Pre-app) |
Clinical Faculty |
Federal |
Ovarian Cancer |
Clinical Translational Leverage Award (W81XWH-14-OCRP-CTLA)
Early-phase, proof-of-principle clinical trials and correlative studies
(retrospective and prospective) to investigate high-impact
research ideas or unmet needs in ovarian cancer. Preliminary
data are required.
| Due Date |
June 3 - Pre-applications
Invited Applications:
August 25 (OSR) |
August 27 (Sponsor) |
| Amount & Project Period: |
$250,000 (Direct Costs) - 2 years
|
| Eligibility: |
At or above Assistant Professor level.
|
| Contact: |
Linda
Nolan, x6071
|
| RFA Link: |
Ovarian Cancer
Research Program
|
|
|
NEW |
| June 3 (Pre-app) |
Clinical Faculty |
Federal |
Ovarian Cancer |
Ovarian Cancer Academy Dean and Assistant Dean (Leadership)
Award
Goal is to develop successful, highly productive ovarian cancer
researchers in a collaborative research training environment. It
is a virtual career development and research training platform
consisting of Early-Career Investigator/Designated Mentor pairs
from different institutions and one Academy Dean.
| Due Date |
June 3 - Pre-applications
Invited applications:
August 25 (OSR) |
August 27 (Sponsor) |
| Amount & Project Period: |
$1,200,000 (Combined direct costs for dean and
assistant dean awards) - 5 years |
| Eligibility: |
Established ovarian cancer investigators having
current and past research funding in this area and a record of
peer-reviewed ovarian cancer publications. |
| Contact: |
Linda
Nolan, x6071
|
| RFA Link: |
Ovarian Cancer
Research Program
|
|
|
NEW |
| June 3 (Pre-app) |
Jr. Faculty |
Federal |
Ovarian Cancer |
Ovarian Cancer Academy - Early-Career Investigator
Goal is to develop successful, highly productive ovarian cancer
researchers in a collaborative research training environment. It
is a virtual career development and research training platform
consisting of Early-Career Investigator/Designated Mentor pairs
from different institutions and one Academy Dean.
| Due Date |
June 3 - Pre-applications
Invited applications:
August 25 (OSR) | August 27 (Sponsor)
|
| Amount & Project Period: |
$725,000 (Direct Costs) - 5
years
|
| Eligibility: |
ECI
Applicant must be w/in first 3 years of first faculty position
and have an
institutional commitment of at least 50% protected time and >25% effort to this award.
Applicant must have institutional support of
>$50,000/year
for support of career development of Early Career Investigator.
Designated Mentor
Must have current ovarian cancer research funding, be an established
ovarian cancer researcher, and must demonstrate a commitment of at least
10% effort for mentoring and participating in off-site Academy
activities.
|
| Contact: |
Linda Nolan, x6071
|
| RFA Link: |
Ovarian Cancer
Research Program
|
|
|
NEW |
| June 3 (Pre-App) |
All Faculty |
Federal |
Ovarian Cancer |
Investigator-initiated Research Award
Rationale for a research idea may be derived from a laboratory
discovery, population-based studies, a clinician's first-hand
knowledge of patients, or anecdotal data. Must include
preliminary data that is relevant to ovarian cancer and supports
the proposed project. Research involving human subjects and
human anatomical substances is permitted, but award cannot be
used to conduct clinical trials.
| Due Date |
June 3 (Pre-applications)
Invited Applications:
August 25 (OSR) | August 27 (Sponsor)
|
| Amount & Project Period: |
$450,000 (Direct Costs) - 3 years
|
| Eligibility: |
Independent investigator at or above Assistant
Professor
|
| Contact: |
Linda
Nolan, x6071
|
| RFA Link: |
Ovarian Cancer
Research Program
|
|
 |
June 3 (LOI)
July 11 (OSR)
July 15 (Sponsor) |
All Faculty |
Non-federal |
Blood Cancers |
Quest for Cures
To identify and develop safer, more effective treatment
paradigms for patients with hematological malignancies.
| Due Date |
June 3 (LOI) by 3:00pm ET
Completed applications:
July 11 (OSR)
July 15 (Sponsor) |
| Amount & Project Period: |
$360,036/year (direct costs) - 2
years
|
| Eligibility: |
All Faculty
|
| Contact: |
Linda
Nolan, x6071
|
| RFA Link: |
RFA:
Quest for Cures |
Guidelines and Instructions
|
|
|
NEW
|
June 3 (OSR)
June 5 (Sponsor) |
All Faculty |
Federal |
Health Stigmas |
Research to Characterize and Reduce Stigma to Improve Health
Research addressing health-related aspects of stigma, including
etiology and perpetuation of stigma; its impact on physical and
mental health, well-being, life course development, and aging;
its influence on health behaviors and on use, access to, and
quality of received healthcare services; its contribution to
health disparities affecting vulnerable demographic groups; and
intervention strategies to reduce health-related stigma.
| Due Date |
June 3 (OSR) | June 5
(Sponsor)
|
| Amount & Project Period: |
Budget not limited - 5 years
|
| Eligibility: |
All Faculty
|
| Contact: |
Linda
Nolan, x6071
|
| RFA Link: |
PA-13-248
|
|
|
|
June 3 (OSR)
June 5 (sponsor) |
All Faculty |
Federal |
Health Outcomes & Behavior |
Behavioral Interventions to Address Multiple Chronic Health
Conditions in Primary Care
Seeks applications proposing to use a common conceptual model to
develop behavioral interventions to modify health behaviors and
improve health outcomes in patients with comorbid chronic
diseases and health conditions.
| Due Date |
June 3 (OSR)
June 5 (Sponsor) |
| Amount & Project Period: |
Budget not limited - 5 years |
| Eligibility: |
All Faculty |
| Contact: |
Linda
Nolan, x6071 |
| RFA Link: |
PA-14-114 |
|
|
|
| Various |
Postdocs & All Faculty |
Federal |
Pain Management |
Mechanisms, Models, Measurement, & Management in Pain
Research
To stimulate and foster a wide range of basic, clinical, and translational
studies on pain.
| Due Date |
R01: June 3 (OSR)
| June 5 (Sponsor)
R21: June 12 (OSR) | June 16
(Sponsor)
|
| Amount & Project Period: |
R01: Budget not limited - 5
years
R21: $275,000 (direct costs) - 2 years
|
| Eligibility: |
All Ranks
|
| Contact: |
Linda Nolan, x6071
|
| RFA Link: |
R01:
PA-13-118 | R21:
PA-13-119
|
|
|
|
| Various |
Postdocs & Faculty |
Federal |
Patient Outcomes |
Dissemination and Implementation Research in Health
Identify, develop, evaluate & refine effective methods, systems,
infrastructures, & strategies to implement research-tested
health behavior change interventions, evidence-based prevention,
early detection, diagnostic, treatment & management, quality of
life improvement services, data monitoring and surveillance
reporting tools into public health and clinical practice
settings that focus on patient outcomes.
| Due Date |
R01: June 3 (OSR) |
June 5 (Sponsor)
R03 & R21: June 12 (OSR) | June 16
(Sponsor)
|
| Amount & Project Period: |
R01: Budget not limited - 5
years
R03: $100,000 direct costs - 2 years
R21: $275,000 direct costs - 2 years
|
| Eligibility: |
All Ranks
|
| Contact: |
Linda
Nolan, x6071
|
| RFA Link: |
R01:
PAR-13-055 | R03:
PAR-13-056 | R21:
PAR-13-054
|
|
|
|
June 3 (OSR)
June 5 (Sponsor) |
All Faculty |
Federal |
Bioengineering |
Bioengineering Research Grants (BRG)
To encourage applications that: 1) Apply a multidisciplinary approach to
solving a biomedical problem; and 2) Integrate, validate,
translate or otherwise accelerate adoption of promising tools,
methods & techniques for a specific research or clinical
problem in basic, translational, or clinical science and
practice.
| Due Date |
June 3 (OSR)
June 5 (Sponsor) |
| Amount & Project Period: |
Budget not limited - 5 years
|
| Eligibility: |
All Faculty
|
| Contact: |
Linda
Nolan, x6071
|
| RFA Link: |
PA-13-137
|
|
NEW |
June 6 (OSR)
June 10 (Sponsor) |
Research Scientists/Jr. Faculty |
Non-federal |
Biomedical Science |
2015 Vilcek Prize for Creative Promise in Biomedical Science
Awards in basic, applied, and/or translational biomedical science.
Candidates with exceptional research contributions to progress
in biomedical sciences; as demonstrated in quality and
significance of research, publication record, and ability to
communicate significance of research to a scientifically
literate audience.
| Due Date |
June 6 (OSR)
June 10 (Sponsor) |
| Amount & Project Period: |
$50,000 (Indefinite project period) |
| Eligibility: |
Applicants must be foreign-born, naturalized
citizens or possess resident green cards and must hold a full time
position. Read the rest of the eligibility guidelines carefully
before applying. |
| Contact: |
Shaina
Sine, x3658
|
| RFA Link: |
Vilcek Foundation
|
|
 |
June 4 (OSR)
June 6 (Sponsor) |
Jr. Faculty |
Non-federal |
Pancreatic Cancer |
AGA-Aptalis Research Award in Pancreatic Disease
Supports young investigators with research into exocrine
pancreatic disorders, including pancreatic cancer.
| Due Date |
June 4 (OSR) |
June 6 (Sponsor) |
| Amount & Project Period: |
$50,000/year for 2 years |
| Eligibility: |
AGA membership is required.
Applicants must be full time faculty by June 1, 2014 and have less than
7 years after first appointment. |
| Contact: |
Linda
Nolan, x6071 |
| RFA Link: |
AGA-Aptalis Research Award |
|
NEW |
June 6 (OSR)
June 8 (Sponsor) |
All Faculty |
Federal |
Prevention & Control |
Fundamental Mechanisms of Affective & Decisional Processes
in Cancer Control
Basic affective science projects should have key downstream consequences
for single and multiple event decisions and behaviors across the
cancer prevention and control continuum.
| Due Date |
June 6 (OSR) | June 8
(Sponsor) |
| Amount & Project Period: |
$450,000/year direct costs for 5
years. |
| Eligibility: |
All faculty |
| Contact: |
Linda Nolan, x6071 |
| RFA Link: |
PAR-14-067 |
|
NEW |
| June 10 (Pre-app) |
Jr. Faculty |
Federal |
Career Development |
Career Development Award
Career Development Award supports impactful research projects with an
emphasis on discovery.
| Due Date |
June 10 - Pre-applications
Invited applications:
September 18 (OSR) | September 22 (Sponsor) |
| Amount & Project Period: |
$360,000 over 3 years |
| Eligibility: |
Applicants must be within 7 years of first
faculty appointment with a minimum of 30% protected time for proposed
research. |
| Contact: |
Linda Nolan, x6071
|
| RFA Link: |
W81XWH-14-PCRP-CDA
|
|
|
NEW |
| June 10 (Pre-app) |
Jr. Faculty |
Federal |
Special Focus Ideas |
Idea Award with Special Focus
To be considered for funding, applications for the PRCRP Idea Award with
Special Focus must address at least one of the
Topic Areas as directed by Congress. Research applications
in the areas of breast, prostate, lung (excluding mesothelioma),
or ovarian cancer will not be accepted.
| Due Date |
June 10: Pre-applications
Invited Applications:
September 15 (OSR)
September 17 (Sponsor)
|
| Amount & Project Period: |
$300,000 direct costs over 2 years
|
| Eligibility: |
Jr. Faculty at or above Assistant Professor
|
| Contact: |
Linda
Nolan, x6071
|
| RFA Link: |
W81XWH-14-PRCRP-IA
|
|
 |
June 12 (OSR)
June 16 (Sponsor) |
Grad Students/Postdoc
fellows/Med Students/Nurse Researchers |
Non-federal |
Lung Cancer |
Lung Cancer Research Foundation Award
The Lung Cancer Research Foundation welcomes submissions of grant requests
for medical/scientific research projects covering all aspects of
lung cancer research. Grant requests can include new project
submissions, as well as requests for renewal of current funding.
| Due Date |
June 12 - OSR
June 16 - Sponsor
|
| Amount & Project Period: |
$50,000 for 1 year
|
| Eligibility: |
Graduate Students, postdoctoral researchers,
physicians, medical students, & nurse researchers
|
| Contact: |
Linda
Nolan, x6071
|
| RFA Link: |
LCRF
2014 Grants
|
|
NEW |
| June 16 (LOI) |
HOPA Members |
Non-federal |
Hematology/Oncology |
The Hematology/Oncology Pharmacy Association (HOPA)
Foundation 2014 Research Fund Award
To facilitate the efforts of hematology/oncology pharmacists working to
optimize the care of individuals affected by cancer.
| Due Date |
June 16 - Letter of Intent
Invited Applications Due:
September 11 (OSR)
September 15 (Sponsor) |
| Amount & Project Period: |
$50,000 total for 1 year
|
| Eligibility: |
HOPA Members only
|
| Contact: |
Linda
Nolan, x6071
|
| RFA Link: |
2014 HOPA Research Fund Award
|
|
NEW |
| June 27 (LOI) |
All Faculty |
Non-Federal |
PCO Evaluations |
Large Pragmatic Studies to Evaluate Patient-Centered
Outcomes
This is a pre-announcement. Eligible studies compare two or more
alternatives for addressing prevention, diagnosis, treatment, or
management of a disease or symptom; improving health care
system-level approaches to managing care; or eliminating health
or healthcare disparities.
| Due Date |
June 27 - Letter of Intent
Invited Applications:
October 31 (OSR)
November 4 (Sponsor) |
| Amount & Project Period: |
$10,000,000 direct costs over 5 years
|
| Eligibility: |
All Faculty
|
| Contact: |
Linda Nolan, x6071
|
| RFA Link: |
Pre-Announcement |
Upcoming Opportunities
|
|
 |
June 26 (OSR)
June 30 (Sponsor) |
MD, PhD or MD/PhD |
Non-Federal |
Leukemia |
Children's Leukemia Research Association, Inc.
Seeks to fund research grants for doctors who are conducting the
most promising research into leukemia, in the hopes of isolating
the causes and finding a cure for this dread disease.
| Due Date |
October 31 - OSR
November 4 - Sponsor |
| Amount & Project Period: |
$30,000 total for 1 year
|
| Eligibility: |
MDs, PhDs or MD/PhDs conducting leukemia
research.
|
| Contact: |
Linda Nolan, x6071
|
| RFA Link: |
CLRA Research Grants
|
|
 |
June 27 (OSR)
July 1 (Sponsor) |
Jr. Faculty
Clinical Fellows |
Non-Federal |
Basic or Trans/Clin Res |
Damon Runyon-Rachleff Innovation Award
Specifically designed to provide funding to extraordinary early
career researchers with an innovative new idea but without
sufficient preliminary data to obtain traditional funding.
Research must be novel and have strong potential for high impact
in the cancer field.
|
NEW |
June 27 (OSR)
July 1 (Sponsor) |
Postdocs |
Non-Federal |
Biomedical Science |
The Helen Hay Whitney Foundation
Supports early postdoctoral research training in all basic
biomedical sciences.
| Due Date |
June 27 - OSR
July 1 - Sponsor |
| Amount & Project Period: |
Year 1 - $49,000
Year 2 - $50,000
Year 3 - $51,000 |
| Eligibility: |
US citizen postdocs with more than 1 year
training at time of application.
|
| Contact: |
Linda
Nolan, x6071
|
| RFA Link: |
HHWF
Postdoctoral Fellowship
|
|
NEW
|
June 8 (LOI)
July 3 (OSR)
July 8 (Sponsor) |
All Faculty |
Federal |
Cancer Epidemiology |
Core Infrastructure & Methodological Research for Cancer Epi
Cohorts
Support for infrastructure and core functions for existing or new Cancer
Epidemiology Cohorts (CECs).
| Due Date |
June 8 - Letter of intent
July 3 - OSR
July 8 - Sponsor |
| Amount & Project Period: |
Budget not limited for 5 years
|
| Eligibility: |
All Faculty
|
| Contact: |
Linda
Nolan, x6071
|
| RFA Link: |
PAR-14-160
|
|
 |
July 24 (OSR)
July 28 (Sponsor) |
Postdocs |
Non-Federal |
Career Development |
Stand Up To Cancer-Cancer Research UK Translational Research
Fellowship
Translational research addressing critical problems in cancers with
potential to deliver patient benefit.
| Due Date |
July 24 - OSR
July 28 - Sponsor |
| Amount & Project Period: |
$315,000 total costs for 4 years |
| Eligibility: |
Open to US and UK-based individuals holding a
PhD and/or a US medical degree and have less than 2 years of
postdoctoral or clinical research experience. Must identify 1
qualified US host laboratory and mentor, and 1 qualified UK host
laboratory and mentor. Work must be performed in 2 phases: 1 in the
United States and 1 in the United Kingdom. |
| Contact: |
Linda Nolan, x6071
|
| RFA Link: |
SU2C Funding Opportunities - AACR
Cancer Research UK Program
Guidelines |
|
NEW
|
June 24 (LOI)
July 24 (OSR)
July 28 (Sponsor) |
Established
Faculty |
Federal |
Big Science Training |
Pre-doctoral Training in Biomedical Big Data Science
This pre-doctoral training initiative:
1. Requires trainees to work
effectively at the intersection of computer science/informatics,
statistics/mathematics, and biomedical science;
2. Expects active
participation of training faculty from all 3 of these scientific
disciplines working collaboratively as co-mentors of trainees in Big
Data Science; and
3. Develops skills required to participate in a team
approach to solving data-intensive biomedical problems.
| Due Date |
June 24 - Letter of Intent
July 24 (OSR)
July 28 (Sponsor) |
| Amount & Project Period: |
Approximately $350,000 total
costs over 5 year.
|
| Eligibility: |
Established Investigators in
areas relevant to biomedical Big Science Data.
|
| Contact: |
Linda
Nolan, x6071
|
| RFA Link: |
RFA-HG-14-004
|
|
NEW |
July 29 (OSR)
July 31 (Sponsor) |
Clinical/Postdoctoral Fellows
& Faculty |
Non-Federal |
Cutaneous Lymphoma |
2014 CLARIONS Award Program -
Curing Cutaneous Lymphoma by Advancing Research, Innovation
and Offering New Solutions
Innovative research in all areas of cutaneous lymphomas with particular
interest in etiology and risk factors of cutaneous lymphomas,
measures of disease impact on effected individuals and
populations, translating discoveries into diagnostic and
therapeutic advances, optimizing therapies and improving
quality of life for individuals with cutaneous lymphomas.
| Due Date |
July 29 (OSR)
July 31 (Sponsor) |
| Amount & Project Period: |
$25,000 for 1 year |
| Eligibility: |
Investigators at all levels, from clinical and
post‐doctoral fellows to established investigators, are eligible to
receive awards. Medical students and graduate students are not eligible. |
| Contact: |
Linda
Nolan, x6071
|
| RFA Links: |
Research Awards Program
CLARIONS Application Manual
Grant Application |
|
NEW |
August 1 (Pre-app)
August 13 (OSR)
August 15 (Sponsor) |
Jr. Faculty |
Federal |
Breast Cancer |
Breast Cancer Research Program (BCRP) Era of Hope Scholar
Award
Central feature of the award is innovative contribution of Principal
Investigator (PI) toward ending breast cancer. PI should
articulate a vision challenging current dogma and demonstrating
ability to look beyond tradition and convention.
| Due Date |
August 1 (Pre-app)
August 13 (OSR)
August 15 (Sponsor) |
| Amount & Project Period: |
$2,500,000 direct costs for 5 years.
|
| Eligibility: |
Jr. Faculty: Independent investigator within 6 years
of last training position.
|
| Contact: |
Linda Nolan, x6071
|
| RFA Link: |
W81XWH-14-BCRP-EOHS
|
|
NEW |
August 11 (LOI)
Sept. 7 (OSR)
Sept 11 (Sponsor) |
All Faculty |
Federal |
Radiation Dosing |
Decreasing Patient Radiation Dose from CT
Imaging: Achieving Sub-mSv Studies
Research leading to reduction of patient radiation exposure from a routine
CT scan to exposures <1 mSv.
| Due Date |
August 11 (Letter of Intent)
Applications Due:
September 07 (Office of Sponsored Research)
September 11 (Sponsor) |
| Amount & Project Period: |
Unlimited budget for 4 years
|
| Eligibility: |
All Faculty
|
| Contact: |
Linda
Nolan, x6071
|
| RFA Link: |
PAR-12-206
|
|
NEW |
August 19 (OSR)
August 15 (Sponsor) |
All Ranks |
Non-Federal |
Pancreatic Cancer |
Hershberg Foundation for Pancreatic Cancer Research
Seed Grants
To provide start-up funding to test innovative ideas for improving diagnosis and to develop new treatment modalities
in pancreatic cancer; obtain preliminary data required for additional funding
impact on the understanding of pancreatic cancer cell biology, biochemistry, physiology, morphology and response to therapy
and to establish collaborations within the field.
| Due Date |
August 13 (OSR)
August 15 (Sponsor) |
| Amount & Project Period: |
$50,000 for 1 year (Renewable) |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan, x6071
|
| RFA Link: |
Seed Grants
|
|
